SLRX

Salarius Pharmaceuticals Inc. (SLRX) is a clinical-stage biotechnology company headquartered in Houston, Texas, dedicated to developing innovative epigenetic therapies for cancer treatment. With a strong emphasis on addressing substantial unmet medical needs, Salarius is advancing a robust pipeline that leverages unique epigenetic mechanisms to enhance patient outcomes. The company's commitment to rigorous clinical trials not only aims to validate its therapeutic approaches but also positions Salarius as a transformative player in the oncology sector, striving to improve the efficacy of cancer care amidst a competitive landscape.